From: CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Location of CD22
Number
Percent
Cell membrane and cytoplasmic positive
46
52.87
Cell membrane positive
24
27.59
Cell membrane negative
17
19.54